CASP3 and neuroblastoma: To add further preclinical evidence for DS-3032b activity in neuroblastoma, we demonstrated that DS-3032b treatment induced apoptosis in primary neuroblastoma cells (OHC-NB-1) by measuring caspase 3 activity (Figure 4C).